Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 870Neoplasms 657Prostatic Neoplasms 448Lung Neoplasms 361Colorectal Neoplasms 333Carcinoma, Non-Small-Cell Lung 324Leukemia, Myeloid, Acute 256Pancreatic Neoplasms 222Brain Neoplasms 204Multiple Myeloma 202Neoplasm Metastasis 198Carcinoma, Hepatocellular 182Head and Neck Neoplasms 178Glioblastoma 169Precursor Cell Lymphoblastic Leukemia-Lymphoma 167Melanoma 156Ovarian Neoplasms 151Squamous Cell Carcinoma of Head and Neck 150Rectal Neoplasms 135Recurrence 133Hematologic Neoplasms 127Sarcoma 125Uterine Cervical Neoplasms 124Stomach Neoplasms 118Glioma 117Triple Negative Breast Neoplasms 116Carcinoma, Renal Cell 116Motor Activity 101Urinary Bladder Neoplasms 99Colonic Neoplasms 99

Interventions

Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Localized Prostate Cancer × 90 days × Clear all
NCT06825091 2026-06-02

ASPIRE

University Health Network, Toronto

Phase 3 Recruiting
320 enrolled
Genitourinary

Localized Prostate Cancer

NCT06966778 2026-03-16

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

National Taiwan University Hospital

Phase NA Recruiting
135 enrolled
Genitourinary

Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡